BNGO - Company ID 0001411690
The table below shows Bionano Genomics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.73M | $3.42M | $3.06M | $3.56M | $3.63M | $8.79M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $4.37M | $4.13M | $4.53M | $3.49M | $3.35M | $5.32M |
| Inventory | $7.01M | $7.69M | $8.42M | $10.31M | $11.42M | $16.28M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $24.88M |
| $38.98M |
| $48.80M |
| $42.66M |
| $44.93M |
| $46.98M |
| Property, plant & equipment | $13.02M | $14.04M | $16.17M | $17.26M | $18.34M | $20.00M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $47.59M | $64.80M | $79.06M | $76.01M | $78.41M | $87.36M |
| Accounts payable | $4.56M | $5.06M | $5.99M | $6.24M | $6.56M | $8.70M |
| Total current liabilities | $10.04M | $21.23M | $22.98M | $24.18M | $26.41M | $32.95M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $15.98M | $27.34M | $29.26M | $30.64M | $30.23M | $38.49M |
| Retained earnings | -$735.35M | -$727.92M | -$711.69M | -$703.18M | -$696.33M | -$673.10M |
| Total equity | $31.61M | $37.46M | $49.80M | $45.37M | $48.19M | $48.87M |